When the Coronavirus SARS-CoV2 strain pandemic impacted the United States in 2020, NCF Diagnostics’ clinical laboratory was ready. We quickly rolled out the test kits needed to aid physicians in tracking the virus.
Our laboratory is fully equipped with state-of-the-art Quant Studio 12K Flex PCR Machines, MiSeq Next Generation Sequencing platforms, and other highly advanced testing technology. Our seasoned technologists, with decades of combined hands-on experience testing pathogens, were already in place to face the onslaught of the COVID-19 pandemic head-on. Investing in and building testing capacity in advance has proven to serve providers well in dealing with this healthcare emergency.
NCF Diagnostics & DNA Technologies was designed to be receptive to physicians’ specific needs. We work closely with caregivers when diagnosing complex diseases, either pathogen-related or genetically inherited. NCF Diagnostics & DNA Technologies currently offers PCR testing panels for over 225 different pathogens as well as same day and 24-hour turn-around time. These two factors combined drive further precision development in patient care and diagnosis.